scispace - formally typeset
P

Pedro Lopez-Lopez

Researcher at University of Córdoba (Spain)

Publications -  43
Citations -  362

Pedro Lopez-Lopez is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Hepatitis E virus & Hepatitis E. The author has an hindex of 9, co-authored 32 publications receiving 173 citations. Previous affiliations of Pedro Lopez-Lopez include Cordoba University.

Papers
More filters
Journal ArticleDOI

Risk factors associated with hepatitis E virus in pigs from different production systems

TL;DR: The evidence showed that pigs reared on extensive farms are at a higher risk of HEV infection than those reared intensively, and the use of control measures could reduce the risk ofHEV infection in pigs and minimize therisk of zoonotic transmission.
Journal ArticleDOI

Prevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?

TL;DR: A relatively high prevalence of HEV infection in wild boar in the south of Spain is found, suggesting that prevalence may depend on the season when the animal is hunted, and the potential risk of zoonotic transmission could fluctuate.
Journal ArticleDOI

Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar.

TL;DR: The hypothesis that low viral titers may persist in the liver of non-viremic individuals, giving thus the possibility of consumption of contaminated liver of animals diagnosed as HEV-negative in serum, is supported.
Journal ArticleDOI

Hepatitis E Infection in HIV-Infected Patients

TL;DR: Despite the increasing knowledge about the pathogenesis, epidemiology and clinical impact of HEV infection, several major factors are faced by HIV-infected patients, including treatment recommendations, immunization and risk practices.
Journal ArticleDOI

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure.

TL;DR: The objective of this review was to analyze the role of acute hepatitis E virus (HEV) infection in patients with CLD, focusing on the impact of this infection on patient survival and prognosis in several world regions.